Exelixis (EXEL) Net Equity Issued and Repurchased (2011 - 2016)

Exelixis' (EXEL) quarterly Net Equity Issued and Repurchased came in at $37000.0 in Q1 2016, down 99.97% quarter-over-quarter from $145.7 million in Q3 2015.

Exelixis (EXEL) Net Equity Issued and Repurchased (2011 - 2016) Analysis & Trends

Exelixis' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $37000.0 for Q1 2016.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $37000.0 in Q1 2016; TTM through Mar 2016 was $145.7 million, a 4856366.67% increase from a year earlier, with the FY2015 full-year figure at $145.6 million, up 92.55% from the prior year.
  • Net Equity Issued and Repurchased declined to $37000.0 in Q1 2016 per EXEL's latest filing, from $145.7 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $145.7 million in Q3 2015 and bottomed at -$3000.0 in Q4 2014.
  • The 4-year median for Net Equity Issued and Repurchased is $32.5 million (2012), against an average of $47.7 million.
  • Biggest YoY gain for Net Equity Issued and Repurchased was 300.0% in 2012; the steepest drop was 63.77% in 2012.
  • Year by year, Net Equity Issued and Repurchased stood at $46000.0 in 2012, then plunged by 106.52% to -$3000.0 in 2014, then soared by 4855133.33% to $145.7 million in 2015, then tumbled by 99.97% to $37000.0 in 2016.
  • Per Business Quant, the three latest EXEL Net Equity Issued and Repurchased figures stand at $37000.0 (Q1 2016), $145.7 million (Q3 2015), and -$3000.0 (Q4 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2016 37,000.00
Mar 31, 2016 37,000.00
Sep 30, 2015 145.65 Mn
Sep 30, 2015 145.65 Mn
Dec 31, 2014 -3,000.00
Dec 31, 2014 -3,000.00
Mar 31, 2014 75.65 Mn
Mar 31, 2014 75.65 Mn
Jun 30, 2012 46,000.00
Jun 30, 2012 46,000.00
Mar 31, 2012 64.99 Mn
Mar 31, 2012 64.99 Mn
Dec 31, 2011 -2,000.00
Dec 31, 2011 -2,000.00
Jun 30, 2011 -23,000.00
Jun 30, 2011 -23,000.00
Mar 31, 2011 179.40 Mn
Mar 31, 2011 179.40 Mn